Repro Med Systems Inc
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating p… Read more
Repro Med Systems Inc (KRMD) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.004x
Based on the latest financial reports, Repro Med Systems Inc (KRMD) has a cash flow conversion efficiency ratio of 0.004x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($65.46K) by net assets ($16.46 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Repro Med Systems Inc - Cash Flow Conversion Efficiency Trend (1996–2024)
This chart illustrates how Repro Med Systems Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Repro Med Systems Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Repro Med Systems Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Brightcove Inc
NASDAQ:BCOV
|
0.036x |
|
BANPU POWER
BK:BPP-R
|
-0.005x |
|
BioInvent International AB (publ)
PINK:BOVNF
|
-0.152x |
|
Ramkhamhaeng Hospital Public Company Limited
BK:RAM
|
0.019x |
|
Tongyang Inc
KO:001525
|
-0.001x |
|
Bin Chuan Enterprise Co Ltd
TWO:1569
|
-0.071x |
|
Zhejiang Haisen Pharmaceutical Co. Ltd. A
SHE:001367
|
N/A |
|
Zhejiang Changhua Auto Parts Co Ltd
SHG:605018
|
0.048x |
Annual Cash Flow Conversion Efficiency for Repro Med Systems Inc (1996–2024)
The table below shows the annual cash flow conversion efficiency of Repro Med Systems Inc from 1996 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $16.81 Million | $-319.72K | -0.019x | +92.09% |
| 2023-12-31 | $20.35 Million | $-4.89 Million | -0.240x | -39.33% |
| 2022-12-31 | $31.33 Million | $-5.40 Million | -0.173x | -45.79% |
| 2021-12-31 | $36.50 Million | $-4.32 Million | -0.118x | -475.63% |
| 2020-12-31 | $36.16 Million | $-743.32K | -0.021x | -172.05% |
| 2019-12-31 | $11.24 Million | $320.62K | 0.029x | -82.72% |
| 2018-12-31 | $8.96 Million | $1.48 Million | 0.165x | +40.73% |
| 2017-12-31 | $7.67 Million | $899.91K | 0.117x | +336.21% |
| 2016-12-31 | $6.68 Million | $-331.62K | -0.050x | -117.56% |
| 2015-12-31 | $6.77 Million | $1.91 Million | 0.283x | +114.76% |
| 2014-12-31 | $6.27 Million | $826.10K | 0.132x | -28.37% |
| 2013-12-31 | $5.19 Million | $954.39K | 0.184x | +2.05% |
| 2012-12-31 | $4.36 Million | $784.79K | 0.180x | +14.10% |
| 2011-12-31 | $3.55 Million | $560.60K | 0.158x | -67.34% |
| 2010-12-31 | $2.13 Million | $1.03 Million | 0.483x | +30.72% |
| 2009-12-31 | $1.03 Million | $382.30K | 0.370x | -50.62% |
| 2008-12-31 | $705.09K | $528.18K | 0.749x | +483.59% |
| 2007-12-31 | $-602.26K | $117.61K | -0.195x | -247.35% |
| 2006-12-31 | $-645.83K | $-85.59K | 0.133x | -45.57% |
| 2005-12-31 | $-569.82K | $-138.75K | 0.243x | -51.70% |
| 2004-12-31 | $-380.26K | $-191.69K | 0.504x | +150.37% |
| 2003-12-31 | $-173.46K | $-34.92K | 0.201x | -32.76% |
| 2002-12-31 | $61.19K | $18.32K | 0.299x | +315.55% |
| 2001-12-31 | $337.38K | $-46.87K | -0.139x | +29.35% |
| 2000-12-31 | $694.45K | $-136.56K | -0.197x | -234.46% |
| 1999-12-31 | $657.91K | $96.22K | 0.146x | +171.80% |
| 1998-12-31 | $540.00K | $-110.00K | -0.204x | -15.43% |
| 1997-12-31 | $1.87 Million | $-330.00K | -0.176x | -266.50% |
| 1996-12-31 | $2.17 Million | $230.00K | 0.106x | -- |